Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 08-2015 | 08-2014 | 08-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -115,909 | N/A | -28,156 | -29,321 | -32,511 |
| Depreciation Amortization | 19 | N/A | 657 | 1,517 | 1,912 |
| Accounts receivable | N/A | N/A | -208 | 589 | -195 |
| Accounts payable and accrued liabilities | 1,252 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,872 | N/A | 1,384 | 1,348 | -1,379 |
| Other Operating Activity | 105,721 | 0 | 3,106 | 3,304 | 4,318 |
| Operating Cash Flow | $-7,045 | $N/A | $-23,217 | $-22,563 | $-27,855 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 24,396 | -3,385 | 16,935 |
| PPE Investments | -110 | N/A | -327 | -204 | -892 |
| Net Acquisitions | -10,952 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-11,062 | $N/A | $24,069 | $-3,589 | $16,043 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -69 | -159 | -240 |
| Common Stock Issued | N/A | N/A | 2,794 | 20,751 | 60 |
| Other Financing Activity | 113,550 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $113,550 | $N/A | $2,725 | $20,592 | $-180 |
| Exchange Rate Effect | N/A | N/A | 1,095 | 102 | -196 |
| Beginning Cash Position | N/A | N/A | 3,423 | 8,881 | 21,069 |
| End Cash Position | 95,443 | N/A | 8,095 | 3,423 | 8,881 |
| Net Cash Flow | $95,443 | $N/A | $4,672 | $-5,458 | $-12,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,045 | N/A | -23,217 | -22,563 | -27,855 |
| Capital Expenditure | -110 | N/A | -387 | -1,014 | -892 |
| Free Cash Flow | -7,155 | 0 | -23,604 | -23,577 | -28,747 |